Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brisdelle for Vasomotor Symptoms in Menopause
NCT01101841Phase 3Completed
- Sponsor
- Noven Therapeutics, LLC
- Start
- Mar 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paroxetine in vasomotor symptoms of menopause (VMS), sponsored by Noven Therapeutics, LLC. Started Mar 2010; status: completed.
02
Drugs
paroxetine
03
Conditions
vasomotor symptoms of menopause (VMS)
Beyond the preview
Go deeper on NCT01101841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101841.